News from Zyme and the companies we work with.
EpilepsyGTx appoints Professor Dimitri Kullmann as Chief Scientific Officer
Appointment of UCL Neurologist will accelerate the delivery of novel gene therapies for refractory epilepsy London, UK, 29 APRIL 2026: EpilepsyGTx, a biotechnology company focused on research and development of [...]
Bio-Rad Launches PTC Harmony 96 and PTC Harmony Deepwell Thermal Cyclers
New PTC Harmony Thermal Cycler Line Expands Access to Reliable, High-Performance PCR Across Academic and Biopharma Laboratories HERCULES, Calif.—April 28, 2026—Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader [...]
PlaqueTec closes $5 million financing
Oversubscribed round backed by existing shareholders Investment will support development of cardiovascular disease database to be used to inform patient stratification and therapeutic development programmes Cambridge, UK, 27 April 2026: [...]
Atelerix launches STORganoid cryo-free preservation solution for complex 3D cell models
Ambient-temperature preservation solution enables reliable storage and shipment of organoids and spheroids, to support growing adoption of New Approach Methodologies Newcastle, UK, 21 April 2026: Atelerix, a biotech company revolutionising [...]
Atelerix forms strategic partnership with JH Health Ltd to expand non-cryogenic cell preservation capabilities in the Middle East
Agreement grants JH Health exclusive rights to use and distribute Atelerix’s portfolio of non-cryogenic preservation solutions in the region Expands regional capabilities with funding for high-volume local manufacturing, as well [...]
Bio-Rad Extends Range of Anti-Idiotypic Antibodies and Anti-Fc Mutation Antibodies for Bioanalysis and Drug Monitoring
Expanded antibody portfolio enhances detection of biologics and YTE-modified therapeutics for bioanalytical applications HERCULES, Calif.—April 14, 2026—Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research [...]
OBN rebrands to BioUK in alignment with its mission to catalyse success in UK life sciences
The new name reflects the national reach of the UK life science membership organisation and leverages its wide and long-established portfolio of Bio-prefixed events Announcement follows sustained growth in both [...]
ProImmune Collaborates with The University of Texas Medical Branch to Advance Infectious Disease Research
Development of novel Ankyrons will enable study of emerging high-consequence infectious diseases to inform vaccines and treatments OXFORD, UK — 14 April 2026 — ProImmune, Ltd., a global leader in [...]
VALANX Biotech establishes Scientific Advisory Board to advance ADC therapeutics
John Lambert, Morris Rosenberg and Peter de Waele appointed as Chair and members of the SAB respectively SAB provides scientific expertise and drug development experience, supporting advancement of the Company’s [...]
SPT Labtech and EMBL GeneCore Collaborate to Advance Fully Walkaway Automation in Genomics Workflows
firefly+ liquid handling platform installed at EMBL GeneCore Collaboration to enable more streamlined end-to-end workflows while maintaining sample integrity Cambridge, UK, and Heidelberg, Germany, 13 April 2026: SPT Labtech, a [...]
FairJourney Bio Opens Cryo-EM Structural Biology Facility in San Diego
Antibody discovery expert expands presence in US biotech ecosystem with world-leading atomic-resolution structural biology capabilities SAN DIEGO, USA, 10 April 2026: FairJourney Bio (FJBio), a global antibody discovery contract research [...]
William Blair Analysts Name Carterra a Winner in Life Science Tools for Enabling AI Drug Discovery at Unprecedented Scale
Carterra, with its HT-SPR technology platforms, is listed alongside large public companies as a technology provider to capitalize on the likely growth in wet lab work driven by the increasing [...]
